Previous 10 | Next 10 |
Ra Medical Systems, Inc. (NYSE: RMED) is conducting a study to demonstrate the DABRA Excimer Laser System delivers effective, long lasting results and a low reintervention rate for patients with peripheral artery disease (PAD). The study will gather data two years post-treatment in up to 2...
NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. (Ra Medical or the “Company”) (NYSE:RMED) of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal ...
Ra Medical Systems, Inc. (NYSE: RMED) Elias Kassab, MD, presented his successful experience using the DABRA laser system. “We have found that DABRA is successful in treating challenging lesions including long and severely c...
Ra Medical Systems, Inc. (NYSE: RMED) today announced that Dr. Mohammad Ansari will present DABRA as a treatment for critical limb ischemia (CLI) during a scientific case review May 21 at the SCAI annual meeting in Las Vegas. “The unique DABRA catheter and laser system is a...
Glancy Prongay & Murray LLP (“GPM”) announces the continuation of its investigation on behalf of Ra Medical Systems, Inc. (“Ra Medical” or the “Company”) (NYSE: RMED ) investors concerning the Company and its officers’ possible violatio...
Ra Medical Systems, Inc. (NYSE: RMED) filed a complaint today in the United States District Court for the Southern District of California alleging Mr. Uri Geiger, Chairman of Strata Skin Sciences, Inc. and managing partner of Accelmed (Strata’s majority stockholder), undertook a cam...
Ra Medical Systems, Inc. (NYSE: RMED) today announced its investment to support high quality patient care in Office Interventional Suites through its Platinum Partnership, the highest level of commitment, with the Outpatient Endovascular and Interventional Society (OEIS). Ra Medical System...
Ra Medical Systems, Inc. (RMED) Q1 2019 Earnings Conference Call May 13, 2019 4:30 PM ET Company Participants Kevin McCabe – LHA Investor Relations Dean Irwin – Chief Executive Officer Tom Fogarty – Chief Commercial Officer Andrew Jackson – Chief Fin...
Ra Medical Systems (NYSE: RMED ): Q1 GAAP EPS of -$1.16 misses by $0.76 . More news on: Ra Medical Systems, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Submits IDE for atherectomy clinical trial with DABRA excimer laser system Conference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc . (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatolog...
News, Short Squeeze, Breakout and More Instantly...
Ra Medical Systems Inc. Company Name:
RMED Stock Symbol:
NYSE Market:
Ra Medical Systems Inc. Website:
Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023 FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced that its Board of Directors has approved cha...
First patent out of six applications on file for LockeT product FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Ent...
Catheter Precision's VIVO System Has Been Utilized in over 1,000 Procedures FORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricula...